Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Depaoli, MR; Bischof, H; Eroglu, E; Burgstaller, S; Ramadani-Muja, J; Rauter, T; Schinagl, M; Waldeck-Weiermair, M; Hay, JC; Graier, WF; Malli, R.
Live cell imaging of signaling and metabolic activities.
Pharmacol Ther. 2019; 202:98-119
Doi: 10.1016/j.pharmthera.2019.06.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Bischof Helmut
-
Depaoli Maria Rosa
-
Malli Roland
- Co-Autor*innen der Med Uni Graz
-
Burgstaller Sandra
-
EROGLU Emrah
-
Graier Wolfgang
-
Ramadani-Muja Jeta
-
Rauter Thomas
-
Schinagl Maximilian
-
Waldeck-Weiermair Markus
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
The interplay of metabolic and signaling processes is prerequisite for the functionality of cells. Any disturbances may have severe consequences, resulting in the development of diseases. However, the complex coordination of metabolism and signaling events makes it difficult to decipher the link between molecular irregularities and pathogenesis. An excellent way to provide more clarity is to see into the living cell and watch cellular processes in real-time, with the add-on of being able to manipulate certain processes. Live cell imaging enables us to do exactly that, with steadily improving spatial and temporal resolution. Modern genetically encoded fluorescent probes in combination with state-of-the-art high-resolution imaging devices have proven themselves as a valuable approach for monitoring, manipulating and ultimately understanding the interaction of cell metabolism and signaling. These probes also represent powerful tools for detecting biomarkers of disease, identifying new drug targets and elucidating drug actions at the cellular to the molecular level.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.